Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$1.7M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$279M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| de los Pinos Elisabet | Jan 21, 2025 | Sell | 15,955 | $7.6704 | $120,000 |
| Elazzouzi Amy | Jan 21, 2025 | Sell | 1,001 | $7.6715 | $7,700 |
| Hopkins Janet Jill | Nov 18, 2024 | Sell | 11,822 | $9.3608 | $110,000 |
| de los Pinos Elisabet | Oct 29, 2024 | Sell | 9,200 | $10.7378 | $99,000 |
| Elazzouzi Amy | Oct 29, 2024 | Sell | 553 | $10.7385 | $5,900 |
| Feder Julie B | Oct 18, 2024 | Sell | 25,131 | $12.0314 | $300,000 |
| de los Pinos Elisabet | Oct 18, 2024 | Sell | 24,992 | $12.0374 | $300,000 |
| Plavsic Mark | Oct 16, 2024 | Sell | 7,383 | $9.85 | $73,000 |
| de los Pinos Elisabet | Jan 23, 2024 | Sell | 15,853 | $7.6415 | $120,000 |
| Feder Julie B | Jan 23, 2024 | Sell | 6,609 | $7.6443 | $51,000 |
| Matrix Capital Management Company, LP | Nov 9, 2023 | Buy | 1,560,000 | $9 | $14M |
| Johnson David Michael | Nov 8, 2023 | Buy | 10,000 | $7.3 | $73,000 |
| Johnson David Michael | Nov 8, 2023 | Buy | 9,601 | $7.3 | $70,000 |
| Johnson David Michael | Nov 7, 2023 | Buy | 76,000 | $7.17 | $540,000 |
| Johnson David Michael | Nov 7, 2023 | Buy | 47,000 | $7.17 | $340,000 |
| de los Pinos Elisabet | Nov 6, 2023 | Sell | 7,449 | $12.0299 | $90,000 |
| Feder Julie B | Nov 6, 2023 | Sell | 3,900 | $12.0651 | $47,000 |
| Feder Julie B | Oct 30, 2023 | Sell | 3,385 | $6.8215 | $23,000 |
| de los Pinos Elisabet | Oct 30, 2023 | Sell | 9,586 | $6.8306 | $65,000 |
| Johnson David Michael | Oct 4, 2023 | Buy | 6,566 | $8.6068 | $57,000 |
| Johnson David Michael | Oct 3, 2023 | Buy | 13,500 | $8.2713 | $110,000 |
What's the latest insider transaction for Aura Biosciences?
The most recent insider transaction for Aura Biosciences was conducted by de los Pinos Elisabet, who sold 15,955 shares on January 21, 2025 at a price of $7.67 per share.
Which insider bought the most AURA stock over the last two years?
Matrix Capital Management Company, LP has bought the most AURA stock in the last 2 years, with a total value of $14M.
Which insider has sold the most AURA stock over the last two years?
de los Pinos Elisabet has sold the most AURA stock in the last 2 years, with a total value of $800,000.
What is the total value of insider transactions for Aura Biosciences (AURA) in the last 2 years?
According to our estimates, the total value of insider transactions for Aura Biosciences in the last 2 years is positive, amounting to $14M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Aura Biosciences' market confidence?
Over the last 2 years, insider transactions for Aura Biosciences have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
